Tau (MAPT) Human Gene Knockout Kit (CRISPR)
CAT#: KN413312
MAPT - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
KN2.0 knockout kit validation
USD 1,290.00
2 Weeks*
Specifications
Product Data | |
Format | 2 gRNA vectors, 1 linear donor |
Donor DNA | EF1a-GFP-P2A-Puro |
Symbol | Tau |
Locus ID | 4137 |
Disclaimer | The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process. |
Reference Data | |
RefSeq | NM_001123066, NM_001123067, NM_001203251, NM_001203252, NM_005910, NM_016834, NM_016835, NM_016841, NM_173727 |
Synonyms | DDPAC; FTDP-17; MAPTL; MSTD; MTBT1; MTBT2; PPND; PPP1R103; TAU |
Summary | 'This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]' |
Documents
Product Manuals |
FAQs |
Resources
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN213312 | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN213312BN | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN213312LP | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
KN213312RB | MAPT - human gene knockout kit via CRISPR, HDR mediated |
USD 1,290.00 |
|
GA102816 | MAPT CRISPRa kit - CRISPR gene activation of human microtubule associated protein tau |
USD 1,290.00 |
{0} Product Review(s)
Be the first one to submit a review